Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2388 of 5804
-
Wearable device could monitor brain shunt function from home
Knowledge-focused Recruiting nowThis study evaluates the performance of a device for non-invasively assessing cerebrospinal fluid (CSF) shunt flow over multiple measurements performed by a study subject during activities of daily living and sleep
Phase: NA • Sponsor: Rhaeos, Inc. • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Fiber fix for asthma? new study tests gut health link
Disease control Recruiting nowRandomized controlled trial of soluble fiber (Fruitafit Inulin). Participants will complete an ASA 24 dietary recall questionnaire to access their fiber intake. If eligible for the study, participants will be supplemented to their target fiber dosage with either soluble fiber (Fr…
Phase: PHASE2 • Sponsor: Phoenix Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New spray aims to speed healing of stubborn diabetic foot sores
Symptom relief Recruiting nowELU42 01 01 (SuperHealer42) is a Phase I/IIA open label study sponsored by Eluciderm, Inc. that evaluates the safety and preliminary effectiveness of ELU42, a topical small molecule designed to modulate Wnt signaling, for the treatment of chronic diabetic foot ulcers (DFU). ELU42…
Phase: PHASE1, PHASE2 • Sponsor: Eluciderm Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Gentler workout with blood flow cuffs may beat heavy lifting for back pain
Symptom relief Completedhis randomized clinical trial aims to compare the effects of low-load blood flow restriction (LL-BFR) training and traditional heavy-load resistance training (HL-RT) on male athletes with sub-acute non-specific low back pain. Participants will be randomly assigned to either the L…
Phase: NA • Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 11:04 UTC
-
Virtual driving coach could cut crashes for ADHD teens
Symptom relief Recruiting nowThis study aims to evaluate a new driving simulator, called ADRIS 2.1, developed for adolescents aged 13-18 years with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a common neurodevelopmental disorder that can affect attention, self-control, and decision-making. These…
Phase: NA • Sponsor: Istituto Giannina Gaslini • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New PAH drug shows promise in Long-Term safety study
Disease control Recruiting nowThe purpose of this study is to learn about the long-term safety, tolerability and effects of the study medicine (PF-07868489) for the possible treatment of PAH. PAH is a condition in which there is high blood pressure in the arteries that carry blood from the heart to the lungs.…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Cancer patients with vein clots get a closer look: new study aims to fill treatment gap
Knowledge-focused Recruiting nowSuperficial venous thrombosis (SVT) is very common in clinical practice. What's more, around 15- 20% of SVTs occur in the context of cancer. Today, cancer patients are excluded from therapeutic trials for DVT. There is therefore no high-level evidence-based treatment recommendati…
Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New eczema drug shows promise in early trial
Disease control OngoingThe main purpose of this Ph2a study is to evaluate the preliminary efficacy, safety and tolerability of GIA632 when administered to adult participants with moderate to severe atopic dermatitis (AD).
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo may shield liver during cancer surgery
Disease control Recruiting nowA multicenter, open-label, randomized, controlled study. It is proposed to evaluate the treatment plan of receiving 930mg polyene phosphatidylcholine injection one day before the operation, twice a day, and 930mg polyene phosphatidylcholine injection twice a day,combined with 100…
Phase: PHASE4 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Electric current may boost Methotrexate's power against vitiligo
Disease control Not yet recruitingVitiligo is a common autoimmune depigmenting disorder characterized by selective destruction of melanocytes. Methotrexate (MTX) has shown potential in stabilizing disease activity and promoting repigmentation; however, systemic administration may cause hepatotoxicity. This pilot …
Phase: NA • Sponsor: Pharos University in Alexandria • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Heart failure patients may bounce back faster with early rehab
Symptom relief CompletedAcute decompensated heart failure (ADHF) is a severe condition characterized by rapid deterioration of cardiac function, leading to impaired oxygen delivery and multi-organ dysfunction. ADHF often results in reduced physical and respiratory capacity, greater dependence on oxygen …
Phase: NA • Sponsor: Izmir Bakircay University • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can weight loss surgery boost your brainpower? new study investigates
Knowledge-focused Recruiting nowThe goal of the study to understand the effects of weight loss and improvements in diabetes following bariatric surgery on brain function and thinking. This study will also examine whether non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention initiated 30 days p…
Phase: NA • Sponsor: University of Florida • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
AI chatbot aims to ease postpartum loneliness and boost pelvic floor health
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth. The main questions this study aims to answer are:…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Can a common antidepressant help seniors sleep better?
Symptom relief Recruiting nowThis study aims to evaluate how effective trazodone is in treating insomnia in adults aged 65 years and older. The main question it aims to answer is : \- Is trazodone more effective than a placebo in reducing the severity of insomnia symptoms in older adults? Participants will…
Phase: PHASE2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Simple smell and taste exercises may bring flavor back to cancer patients' meals
Symptom relief Recruiting nowA multicentre non-blinded randomised intervention trial with a parallel cluster design. The multicentre study will be performed at 12 hospitals in the Netherlands. A parallel cluster design per hospital was selected to prevent contact between participants in the same hospital who…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Lifestyle program aims to cut colon cancer risk in high-risk individuals
Prevention Recruiting nowBackground Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challen…
Phase: NA • Sponsor: China Medical University, China • Aim: Prevention
Last updated Jun 27, 2026 08:01 UTC
-
Ultrasound boosts steroid cream for vitiligo in new trial
Disease control Recruiting nowVitiligo is a skin disorder that results in the formation of depigmented patches or hypopigmented macules due to selective destruction or reduction of melanocytes the cells that produce pigment in our skin. Vitiligo affects 0.1-2% of the World's population. People of all skin ty…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug targets cancer enzyme in early human trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of MTI-301 in treating patients with solid cancers that have spread from where they first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable) and that …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New scan could sharply improve head & neck cancer surgery
Diagnosis Recruiting nowThe purpose of this study is to evaluate the diagnostic performance of 18F-FDG micro-PET-CT in malignant Head and neck cancer compared to definitive histological analysis (gold standard).
Phase: NA • Sponsor: Centre Henri Becquerel • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
New stimulation pattern could ease tough back pain
Symptom relief Recruiting nowStudy to evaluate the effectiveness of time variant pulse (TVP)-SCS in patients with chronic pain using commercially approved Boston Scientific SCS Systems per local Instructions for use (IFU). In addition, to compile real-world clinical outcomes in subjects with chronic, intrac…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC